03 Profile
Vital Signsby Bridgehead
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Diabetes
Boaz Hirshberg: no photograph is held, so the sector leader plate is shown instead.
Sector leader
Boaz Hirshberg
Regeneron's head of clinical development for internal medicine
1
0
Oct 2026Nov 2026to date
1
press citation on 1 topic since 2 Oct 2026 · last quoted 2 Oct 2026
02 Quoted on · 1 of 29 topics
Boaz Hirshberg: key facts
- Kind of voice
- Sector leader
- Role
- Regeneron's head of clinical development for internal medicine
- Quoted on
- Diabetes
- Tracked press citations
- 1
- Most recently quoted
- 2 Oct 2026
04 The signal · where Boaz Hirshberg sits on diabetes
Ranked 46= of 100 voices quoted in the press on diabetes, level with 54 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK11 - 2
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)9 - 3
Parth NarendranAcademicProfessor of Diabetes Medicine; Honorary Consultant Physician (leads the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital Birmingham), University of Birmingham8 - 46=Prof. Andrej JanežAcademicProfessor1
- 46=Prof. Karolina Kędzierska-KapuzaAcademicProfessor1
- 46=Boaz HirshbergSector leaderRegeneron's head of clinical development for internal medicine1
- 46=Harini SathanapallyClinicianGeneral Practitioner; Doctoral Fellow, University of Leicester1
- 46=Helen O'NeilClinicianSenior medicines optimisation pharmacist, North East and North Cumbria Integrated Care Board1
Showing the leaders and the ranks around 46=, of 100 voices · See every voice on the topic →
05 On the record · press
What Boaz Hirshberg has said
By outlet · linked articles
- pharmaphorum.com1
Where Boaz Hirshberg has been quoted
- 01New diabetes and obesity studies making waves at EASDpharmaphorum.com · 2 Oct 2026
Verbatim
“Our COURAGE trial not only confirms this concern about muscle loss, but also shows that trevogrumab can be part of the solution, addressing not the quantity, but rather the quality, of weight loss.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
- Branding update for insulin pensDiabetes Research & Wellness Foundation
- DRWF Events: Register now for Diabetes: A Whole Life BlueprintDiabetes Research & Wellness Foundation
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.